Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acquired Immunodeficiency in ANCA Associated Vasculitis
NCT03514979Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Oct 2018
- Primary completion
- Dec 2022
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of pneumococcal conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine in pneumococcal infection, sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Oct 2018; status: completed.
02
Drugs
pneumococcal conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT03514979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03514979.